RICHARD RUTZ: Open Payments
NPI 1760659692 · MASON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,836 in 170 payments from 18 companies in 2025. Trend: 2023 $1,878 · 2024 $1,853 · 2025 $2,836
Food & beverage: $2,836
| Company | Payments | Amount |
|---|---|---|
| Noven Therapeutics, LLC | 35 | $479 |
| Otsuka America Pharmaceutical, Inc. | 26 | $337 |
| ABBVIE INC. | 23 | $314 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $298 |
| Alkermes, Inc. | 13 | $248 |
| Vanda Pharmaceuticals Inc. | 9 | $219 |
| Teva Pharmaceuticals USA, Inc. | 9 | $218 |
| Axsome Therapeutics, Inc. | 7 | $138 |
| Biogen, Inc. | 1 | $119 |
| Neurocrine BioSciences, Inc. | 4 | $97 |
Products named: Xelstrym, REXULTI, VRAYLAR, TRINTELLIX, ARISTADA, AUSTEDO XR, HETLIOZ, Auvelity.
Industry payments across OH — which companies pay providers there.
